Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 13Rectal Neoplasms 10Esophageal Neoplasms 7Colorectal Neoplasms 7Stomach Neoplasms 6Esophageal Squamous Cell Carcinoma 6Uterine Cervical Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Squamous Cell Carcinoma of Head and Neck 4Neuroblastoma 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Colonic Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Lung Neoplasms 3Liposarcoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Prostatic Neoplasms 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Multiple Myeloma 2Melanoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2

Interventions

Radiotherapy 5Cisplatin 5Magnetic Resonance Spectroscopy 3Fluorouracil 3Cetuximab 3Carboplatin 3pembrolizumab 2Taxes 2Surgical Procedures, Operative 2Specimen Handling 2Paclitaxel 2Drug Therapy 2Docetaxel 2(225)Ac-DOTA-c(RGDyK) 2sargramostim 1dehydroftorafur 1Tretinoin 1Sucralfate 1Salts 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Adjuvant 1Radiation 1Platinum 1Neoadjuvant Therapy 1Laryngectomy 1Hydroxyurea 1Chemoradiotherapy 1Cefazolin 1Adjuvants, Pharmaceutic 15-fluoro-3-pyridinecarboxylic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Laryngeal Neoplasms × Neoadjuvant Therapy × Clear all
NCT06957938 2025-05-08

Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma

Fudan University

Phase 3 Not yet recruiting
168 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡